Literature DB >> 8339283

Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy).

L Roncucci1, M Pedroni, R Fante, C Di Gregorio, M Ponz de Leon.   

Abstract

Foci of aberrant crypts (ACF) have been observed on the unsectioned, methylene blue-stained mucosal surface of the human colon. Experimental evidence and the histological features of the lesions suggest that they might be early events in colon cancer development. The main objective of the present study was to evaluate cell kinetic properties of ACF in the human colon. Five samples of colon mucosa were collected immediately after operation following the administration of 500 mg of 5'-bromo-2'-deoxyuridine prior to surgery. ACF were then identified on the fixed, unsectioned, methylene blue-stained mucosal surface under a light microscope. Some specimens containing ACF were serially sectioned perpendicular to the luminal surface of the intestine, along with specimens of normal-appearing mucosa. Several sections were prepared for the immunohistochemical identification of 5'-bromo-2'-deoxyuridine-incorporating cells (in the S phase of the cell cycle). The results of this study demonstrated that aberrant crypts have more cells per crypt than normal glands. Total labeling index and labeling index values in each of the five longitudinal compartments in which each crypt was divided showed an increased total proliferative activity in all ACF examined, although limited to the lower crypt compartments in almost all aberrant crypts evaluated. These findings are in keeping with previous cell kinetic studies and observations in experimental animals and provide evidence of the involvement of human aberrant crypts in the stepwise process leading from normal mucosa to colon cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339283

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Identification of dysplasia in human colonic aberrant crypt foci.

Authors:  I M Siu; T G Pretlow; S B Amini; T P Pretlow
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas.

Authors:  M Anti; A Armuzzi; S Morini; E Iascone; G Pignataro; C Coco; R Lorenzetti; M Paolucci; M Covino; A Gasbarrini; F Vecchio; G Gasbarrini
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 3.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

Review 4.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

5.  Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis.

Authors:  A Kurimasa; H Ouyang; L J Dong; S Wang; X Li; C Cordon-Cardo; D J Chen; G C Li
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 6.  Aberrant crypt foci as microscopic precursors of colorectal cancer.

Authors:  Lei Cheng; Mao-De Lai
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

7.  In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis.

Authors:  J Sträter; K Koretz; A R Günthert; P Möller
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

8.  Aberrant crypt foci in patients with colorectal cancer.

Authors:  L Roncucci; S Modica; M Pedroni; M G Tamassia; M Ghidoni; L Losi; R Fante; C Di Gregorio; A Manenti; L Gafa; M Ponz de Leon
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

9.  Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon.

Authors:  N Yamashita; T Minamoto; M Onda; H Esumi
Journal:  Jpn J Cancer Res       Date:  1994-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.